443TiPFirst-in-human trial design for W0101: A first-in-class antibody-drug conjugate targeting IGF-1R and identification of the target patient population.
Saved in:
| Title: | 443TiPFirst-in-human trial design for W0101: A first-in-class antibody-drug conjugate targeting IGF-1R and identification of the target patient population. |
|---|---|
| Authors: | Gomez-Roca, C A1 (AUTHOR), Garralda-Cabanas, E2 (AUTHOR), Cruzalegui, F3 (AUTHOR), Ausseil, F3 (AUTHOR), Zorza, G3 (AUTHOR), Delfour, O3 (AUTHOR), Besse, J3 (AUTHOR), Akla, B4 (AUTHOR), Gautier, S5 (AUTHOR), Adam, J6 (AUTHOR) |
| Source: | Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 133286284 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 443TiPFirst-in-human trial design for W0101: A first-in-class antibody-drug conjugate targeting IGF-1R and identification of the target patient population. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Gomez-Roca%2C+C+A%22">Gomez-Roca, C A</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Garralda-Cabanas%2C+E%22">Garralda-Cabanas, E</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cruzalegui%2C+F%22">Cruzalegui, F</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ausseil%2C+F%22">Ausseil, F</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zorza%2C+G%22">Zorza, G</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Delfour%2C+O%22">Delfour, O</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Besse%2C+J%22">Besse, J</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Akla%2C+B%22">Akla, B</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gautier%2C+S%22">Gautier, S</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Adam%2C+J%22">Adam, J</searchLink><relatesTo>6</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=133286284 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/annonc/mdy279.430 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: N.PAG Titles: – TitleFull: 443TiPFirst-in-human trial design for W0101: A first-in-class antibody-drug conjugate targeting IGF-1R and identification of the target patient population. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gomez-Roca, C A – PersonEntity: Name: NameFull: Garralda-Cabanas, E – PersonEntity: Name: NameFull: Cruzalegui, F – PersonEntity: Name: NameFull: Ausseil, F – PersonEntity: Name: NameFull: Zorza, G – PersonEntity: Name: NameFull: Delfour, O – PersonEntity: Name: NameFull: Besse, J – PersonEntity: Name: NameFull: Akla, B – PersonEntity: Name: NameFull: Gautier, S – PersonEntity: Name: NameFull: Adam, J IsPartOfRelationships: – BibEntity: Dates: – D: 04 M: 10 Text: 2018 Supplement Type: published Y: 2018 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 29 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |